Clinical trials

Clinical trials web image

A diagnosis of dementia can be distressing for the people concerned and their families. Joining a clinical trial to investigate new treatment options can alleviate some of that stress and provide a sense of hope. 

The Dementia Centre’s clinical trials teams are staffed by industry-recognised professionals with connections to trial sponsors and leading dementia researchers worldwide. 

Our trials investigate the effectiveness of new drug treatments for people living with early-stage dementias and other related conditions.

Participants gain access to new treatments, as well as learning more about their condition and how to manage it. There are no cost involved and assistance with travel can be arranged.

 

Our studies are conducted at:

VIC: HammondCare, 261 Wattletree Road, Malvern. 3144

NSW: Pallister House, Greenwich Hospital, 97-115 River Rd, Greenwich. 2065

 

To discuss trial participation, please contact:

  • Clinical Trial Coordinator VIC
    • Phone (03) 9597 6516
    • Email This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Clinical Trial Coordinator NSW
    • Phone (02) 8437 7358
    • Email This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 

Find out more

Current drug trials open to participants

Jansenn Automomy Study

A randomized, double-blind, placebo-controlled, parallel-group, multicentre study to assess the efficacy and safety of JNJ-63733657, an Anti-tau Monoclonal Antibody, in participants with early Alzheimer’s disease.

Sites: Malvern only.

NovoNordisk EVOKE plus study

A randomised, double-blind, placebo-controlled, clinical trial investigating the effect and safety of oral semaglutide in participants with early Alzheimer’s disease.

Sites: Malvern and Greenwich

Eli Lilly study

Assessment of safety, tolerability and efficacy or LY3372689 in early symptomatic Alzheimer’s disease.

Sites: Malvern and Greenwich